Results 171 to 180 of about 3,236,190 (349)

IgM-Dependent Phagocytosis in Microglia Is Mediated by Complement Receptor 3, Not Fcα/μ Receptor

Journal of Immunology, 2015
Jonathan R. Weinstein, Yi Quan, J. Hanson, Lucrezia Colonna, Michael Iorga, S. Honda, K. Shibuya, A. Shibuya, K. Elkon, T. Möller   +9 more
semanticscholar   +1 more source

Human complement C3b/C4b receptor (CR1) mRNA polymorphism that correlates with the CR1 allelic molecular weight polymorphism.

, 1987
V. Michael Holers, David Chaplin, Joseph F. Leykam, Barbara Gruner, V Kumar, John P. Atkinson   +5 more
openalex   +2 more sources

Interleukin‐6 as a Key Biomarker in Facioscapulohumeral Dystrophy: Evidence From Longitudinal Analyses

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini, Emanuela Martinuzzi, Sandra Dhifallah, Abderhmane Slioui, Angela Puma, Luisa Villa, Michele Cavalli, Andra Ezaru, Jérémy Garcia, Manuela Gambella, Federico Torre, Luca Jacopo Pavan, Nicolas Glaichenhaus, Sabrina Sacconi   +13 more
wiley   +1 more source

More than complementing Tolls: complement–Toll‐like receptor synergy and crosstalk in innate immunity and inflammation

Immunological Reviews, 2016
G. Hajishengallis, John D Lambris
semanticscholar   +1 more source

Amino acid sequence of the alpha subunit of human leukocyte adhesion receptor Mo1 (complement receptor type 3). [PDF]

, 1988
M. Amin Arnaout, S. K. GUPTA, Mark Pierce, Daniel G. Tenen   +3 more
openalex   +1 more source

Prediction Model for Etiologic Differentiation of Isolated Vestibular Syndrome in Emergency Settings

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to develop and validate a predictive model for differentiating central from peripheral etiologies in patients with isolated vestibular syndrome (VS). Methods In this multicenter retrospective cohort study, 506 patients with isolated VS from five hospitals were divided into derivation (n = 301) and validation (n = 205)
Guo Wenting, Du Liping, Yang Yi, Hu Jin, Ye Bijun, Wang Jianer, Liu Shuangsi, Guo Shunyuan, Cai Xiaofeng, Wang Huiyuan, Wu Bin, Yu Xiang, Shi Tianming   +12 more
wiley   +1 more source

Immunomodulatory function of chitosan is dependent on complement receptor 3. [PDF]

Cell Surf
Wagener J, Wang X, Becker KL, Aimanianda V, Valsecchi I, Gresnigt MS, Netea MG, Latge JP, Gow NAR, van de Veerdonk FL.   +9 more
europepmc   +1 more source

CSF Levels of NPTX2 Are Associated With Less Brain Atrophy Over Time in Cognitively Unimpaired Individuals

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Neuronal pentraxin 2 (NPTX2) is a synaptic protein involved in synaptic plasticity and regulation of neuronal excitability. Lower baseline cerebrospinal fluid (CSF) NPTX2 levels have been shown to be associated with an earlier onset of mild cognitive impairment (MCI), a pre‐dementia syndrome, even after CSF Alzheimer's Disease (AD)
Juan P. Vazquez, Corinne Pettigrew, Yuxin Zhu, Claire Anderson, Guray Erus, Christos Davatzikos, Michael Miller, Abhay Moghekar, Sungtaek Oh, Chan‐Hyun Na, Marilyn Albert, Paul Worley, Anja Soldan   +12 more
wiley   +1 more source

The Alzheimer's disease-associated complement receptor 1 variant confers risk by impacting glial phagocytosis. [PDF]

Alzheimers Dement
Daskoulidou N, Shaw B, Zelek WM, Morgan BP.   +3 more
europepmc   +1 more source

Genetic variant in complement receptor 1 (CR1, CD35) is associated with a cluster of severe fatal COVID-19 in a family. [PDF]

J Infect, 2023
Danial-Farran N, Khlaila M, Avraham-Kelbert M, Chazan B, Khayat M, Winder A, Shalev S, Bisharat N.   +7 more
europepmc   +1 more source